Nephrologist Follow-up Versus Usual Care After an Acute Kidney Injury Hospitalization
FUSION
1 other identifier
interventional
200
1 country
4
Brief Summary
The primary objective is to evaluate the impact of an AKI Follow-up Clinic on major adverse kidney events (MAKE) in comparison to hospitalized patients surviving an episode of AKI who are not exposed to the AKI Follow-up Clinic intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2015
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 18, 2015
CompletedFirst Posted
Study publicly available on registry
June 26, 2015
CompletedStudy Start
First participant enrolled
September 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedApril 19, 2018
April 1, 2018
2.8 years
June 18, 2015
April 17, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion with a major adverse kidney event
Composite of chronic dialysis, chronic kidney disease progression, or death
1 year after randomization
Secondary Outcomes (18)
Proportion with a major adverse kidney event
30, 90, 365 days, and 5 years following randomization
Proportion deceased
30, 90, 365 days, and 5 years following randomization
Proportion who require chronic dialysis
30, 90, 365 days, and 5 years following randomization
Proportion with chronic kidney disease progression using CKD-EPI eGFR equation
30, 90, 365 days, and 5 years following randomization
Time to major adverse kidney event
5 years following randomization
- +13 more secondary outcomes
Study Arms (2)
AKI Follow-up Clinic
EXPERIMENTALParticipants randomized to this arm will be referred to the AKI Follow-up Clinic where they will see a nephrologist who will coordinate follow-up care. The target appointment date is within 30 days of hospital discharge. Routine laboratory investigations will be performed at minimum every three months. Additional in-person visits with a nephrologist at the AKI Follow-up Clinic will be determined at the local sites based upon the participant's clinical status. If in-person visits at 12, 24, and/or 36 weeks are not necessary given the patient's clinical status, they may be replaced with a telephone visit
Usual Care
NO INTERVENTIONParticipants randomized to this arm will have a letter outlining their AKI diagnosis mailed to their family physician. Participants may still be referred to a nephrologist by their inpatient or outpatient healthcare provider, but these participants will not have access to the AKI Follow-up Clinic. Rather, they will proceed through the standard local nephrology referral pathway. In addition, all usual care participants will be contacted via telephone by study staff every three months to assess their clinical condition and ensure study engagement. All usual care participants will be offered a nephrologist assessment and/or bloodwork one year after randomization to determine if ongoing nephrology care is indicated based upon the same criteria applied to AKI Follow-up Clinic participants.
Interventions
Participants randomized to this arm will be referred to the AKI Follow-up Clinic where they will see a nephrologist who will coordinate follow-up care. At the AKI Follow-up Clinic, assessment forms that were developed during the pilot study at St. Michael's Hospital may be used, but this decision will be left to individual sites. Routine laboratory investigations will be performed at minimum every three months.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 yrs
- Kidney Disease Improving Global Outcomes (KDIGO) stage 2 AKI and above (including need for dialysis)
You may not qualify if:
- Kidney transplant recipients
- Outpatient baseline eGFR under 30mL/min/1.73m2 (by CKD-EPI equation); ignore if baseline serum creatinine is unavailable
- Patients discharged from hospital with a persistent requirement for renal replacement therapy
- Clinical diagnosis or suspicion of: glomerulonephritis, vasculitis with kidney involvement, hemolytic-uremic syndrome, polycystic kidney disease, myeloma cast nephropathy
- Pregnancy
- Residence at a nursing home facility (rehabilitation and retirement home patients should not be excluded)
- Palliation as primary goal of care (defined as life expectancy ≤ six months or followed by a palliative care physician)
- Patients with previously established and ongoing nephrology follow-up (defined as ≥ one outpatient appointment with a nephrologist in the previous 12 months)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Unity Health Torontolead
- Sunnybrook Health Sciences Centrecollaborator
- University Health Network, Torontocollaborator
- Mount Sinai Hospital, Canadacollaborator
Study Sites (4)
Mount Sinai Hospital
Toronto, Ontario, Canada
St. Michael's Hospital
Toronto, Ontario, Canada
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
University Health Network
Toronto, Ontario, Canada
Related Publications (1)
Robinson C, Hessey E, Nunes S, Dorais M, Chanchlani R, Lacroix J, Jouvet P, Phan V, Zappitelli M. Acute kidney injury in the pediatric intensive care unit: outpatient follow-up. Pediatr Res. 2022 Jan;91(1):209-217. doi: 10.1038/s41390-021-01414-9. Epub 2021 Mar 17.
PMID: 33731806DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ron Wald, MDCM, MPH
Unity Health Toronto
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 18, 2015
First Posted
June 26, 2015
Study Start
September 1, 2015
Primary Completion
July 1, 2018
Study Completion
December 1, 2022
Last Updated
April 19, 2018
Record last verified: 2018-04